- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.18: 2 residues within 4Å:- Chain A: N.266
- Chain B: K.542
Ligand excluded by PLIPNAG.19: 2 residues within 4Å:- Chain A: N.315, Q.564
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain A: N.587, T.588
Ligand excluded by PLIPNAG.21: 2 residues within 4Å:- Chain A: N.600, T.602
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain A: Y.639, N.641
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain A: S.688, N.689
- Chain C: Y.776
Ligand excluded by PLIPNAG.24: 3 residues within 4Å:- Chain A: Y.12, N.45, T.47
Ligand excluded by PLIPNAG.25: 1 residues within 4Å:- Chain A: N.218
Ligand excluded by PLIPNAG.26: 4 residues within 4Å:- Chain B: Y.12, T.13, N.14, N.45
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain B: T.92, N.218
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain B: N.264, E.265, N.266
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain B: N.600, R.630
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain B: N.327, F.355
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain C: N.315, P.563, Q.564, L.566
Ligand excluded by PLIPNAG.32: 5 residues within 4Å:- Chain C: Y.12, T.13, N.14, S.44, N.45
Ligand excluded by PLIPNAG.33: 4 residues within 4Å:- Chain C: N.106, T.108, N.109, V.111
Ligand excluded by PLIPNAG.34: 3 residues within 4Å:- Chain C: T.92, T.98, N.218
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain C: N.600, T.602, Q.628
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain C: Y.639, N.641
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain B: I.774, Y.776
- Chain C: N.689
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain C: A.686, N.1054
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain C: N.327
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain C: N.264, E.265, N.266
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain C: N.587, T.588
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, B. et al., An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike. Cell Rep (2024)
- Release Date
- 2024-05-15
- Peptides
- Spike glycoprotein: ABC
Light chain of D1F6 Fab: DFG
Heavy chain of D1F6 Fab: EHI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DF
MG
NE
EH
QI
R
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, B. et al., An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike. Cell Rep (2024)
- Release Date
- 2024-05-15
- Peptides
- Spike glycoprotein: ABC
Light chain of D1F6 Fab: DFG
Heavy chain of D1F6 Fab: EHI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DF
MG
NE
EH
QI
R